Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04291599 · ClinicalTrials.gov registry record · Phase 2
Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid
A Phase 2 study, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
NCT04291599 is a Phase 2 study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 23 participants.
The verdict
NCT04291599, a Phase 2 study, was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
Study Summary
This will be a phase 2, single-center, unblinded randomized controlled pilot trial of two arms comparing opioid-sparing analgesia to the current Boston Children's Hospital institutional practice which has been reported to predominantly include administration of opioids as a first-line analgesic to pediatric patients who present to the emergency department with a diagnosis of acute pancreatitis (AP). This is a pilot trial for which many outcomes have not previously been studied in the pediatric AP population. The focus of this investigation will be to investigate the magnitude and variability of effect sizes for designing a future multi-center, double-blinded randomized controlled trial.
Interventions
- DRUG Ketorolac
- DRUG Opioid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-03-15 |
| Est. Completion | 2025-07-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04291599
The ClinicalTrials.gov registry entry for NCT04291599 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT04291599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04291599 about?
NCT04291599 is a clinical study titled "Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid". This will be a phase 2, single-center, unblinded randomized controlled pilot trial of two arms comparing opioid-sparing analgesia to the current Boston Children's Hospital institutional practice which has been reported to predominantly include administration of opioids as a first-line analgesic to p...
What is the current status of trial NCT04291599?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2022-03-15. Estimated completion is 2025-07-24.
What interventions are being tested in trial NCT04291599?
The interventions under investigation include: Ketorolac (DRUG), Opioid (DRUG).
Who is sponsoring clinical trial NCT04291599?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.